Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety
- PMID: 26360931
- DOI: 10.1111/pme.12904
Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety
Abstract
Objective: The burgeoning rate of prescription opioid misuse, abuse, addiction, and opioid related overdose deaths has gained substantial professional and national media attention. This manuscript provides a narrative review and critique of the literature on prescription opioid misuse, abuse, addiction and opioid-related mortality and discusses future research needs in this area.
Design: Current literature on misuse, abuse, addiction and opioid related fatalities was reviewed in patients with chronic noncancer pain receiving long-term prescription opioid therapy.
Results: There have been inconclusive results on the efficacy of long-term opioid therapy in patients with chronic pain but moderate level evidence of dose-dependent risk of harm. The estimated prevalence of prescription opioid abuse and opioid use disorders ranges from <1% to 40% due to the paucity of uniform definitions of what constitutes misuse, abuse, and addiction but several recent studies have developed unique methodology to more accurately assess these states in the pain population. The rate of opioid-related overdose deaths is not inconsequential and a number of patient related and medication specific risk factors have been identified that may provide a basis for risk mitigation strategies.
Conclusions: Accurately assessing the prevalence of misuse, abuse, and addiction in the pain population has been challenging due to inconsistent definitions between studies. Additional high-quality research is needed in this area utilizing consistent definitions and in reducing the risk of opioid-related overdose fatalities.
Keywords: Abuse; Chronic Pain; Misuse; Opioid Use Disorder; Opioids; Overdose.
Wiley Periodicals, Inc.
Similar articles
-
The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response.J Pain Palliat Care Pharmacother. 2015 Jun;29(2):102-14. doi: 10.3109/15360288.2015.1037521. J Pain Palliat Care Pharmacother. 2015. PMID: 26095479
-
Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.Pain Physician. 2017 Feb;20(2S):S93-S109. Pain Physician. 2017. PMID: 28226333 Review.
-
Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).Pain Physician. 2017 Feb;20(2S):S111-S133. Pain Physician. 2017. PMID: 28226334
-
Risk Factors for Opioid-Use Disorder and Overdose.Anesth Analg. 2017 Nov;125(5):1741-1748. doi: 10.1213/ANE.0000000000002496. Anesth Analg. 2017. PMID: 29049118 Review.
-
Facing the challenge of pain management and opioid misuse, abuse and opioid-related fatalities.Expert Rev Clin Pharmacol. 2016 Jun;9(6):751-4. doi: 10.1586/17512433.2016.1160776. Epub 2016 Mar 25. Expert Rev Clin Pharmacol. 2016. PMID: 26933873 No abstract available.
Cited by
-
Current State of Opioid Therapy and Abuse.Curr Pain Headache Rep. 2016 May;20(5):34. doi: 10.1007/s11916-016-0564-x. Curr Pain Headache Rep. 2016. PMID: 27048483 Review.
-
Opioid Consumption After Upper Extremity Surgery: A Systematic Review.Hand (N Y). 2024 Sep;19(6):1002-1011. doi: 10.1177/15589447231160211. Epub 2023 Mar 23. Hand (N Y). 2024. PMID: 36960481 Free PMC article.
-
The mitochondrial calcium uniporter contributes to morphine tolerance through pCREB and CPEB1 in rat spinal cord dorsal horn.Br J Anaesth. 2019 Aug;123(2):e226-e238. doi: 10.1016/j.bja.2019.05.027. Epub 2019 Jun 26. Br J Anaesth. 2019. PMID: 31253357 Free PMC article.
-
A Review of the Opioid Epidemic: What Do We Do About It?Pain Ther. 2018 Jun;7(1):23-36. doi: 10.1007/s40122-018-0096-7. Epub 2018 Apr 6. Pain Ther. 2018. PMID: 29623667 Free PMC article. Review.
-
Changes in pain and concurrent pain medication use following compounded topical analgesic treatment for chronic pain: 3- and 6-month follow-up results from the prospective, observational Optimizing Patient Experience and Response to Topical Analgesics study.J Pain Res. 2017 Oct 3;10:2341-2354. doi: 10.2147/JPR.S143513. eCollection 2017. J Pain Res. 2017. PMID: 29042810 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical